Catapult Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$514K Sell
23,940
-136,060
-85% -$3.04M 0.19% 118
2015
Q2
$3.2M Buy
160,000
+120,000
+300% +$2.11M 0.46% 68
2015
Q1
$623K Buy
+40,000
New +$604K 0.08% 189
2014
Q3
Sell
-140,000
Closed -$1.39M 212
2014
Q2
$1.39M Buy
+140,000
New +$1.24M 0.16% 151
2014
Q1
Sell
-29,508
Closed -$261K 213
2013
Q4
$261K Buy
29,508
+4,176
+16% +$33K 0.06% 172
2013
Q3
$179K Sell
25,332
-154,668
-86% -$980K 0.02% 230
2013
Q2
$1.01M Buy
+180,000
New +$862K 0.42% 70

Other funds holding DXCM

Catapult Capital Management's DXCM Position: Q3 2015 in Review

Catapult Capital Management reduced its DexCom (DXCM) stake by 85% in Q3 2015, selling an estimated $3.04M and leaving 23,940 shares worth $514K. The position accounts for 0.19% of the portfolio, ranked #118.

Catapult Capital Management first reported a position in DXCM in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.2M in Q2 2015. 282 funds tracked by Wall St. Rank hold DXCM as of Q3 2015.

  • Catapult Capital Management held 23,940 shares of DexCom worth $514K as of Q3 2015.
  • Catapult Capital Management sold 136,060 DexCom shares in Q3 2015, an estimated $3.04M.
  • DexCom made up 0.19% of Catapult Capital Management's portfolio in Q3 2015, its #118 holding.
  • Catapult Capital Management first reported a position in DexCom in Q2 2013 and has held it in 7 quarters since.
  • Catapult Capital Management's DexCom position peaked at $3.2M in Q2 2015.
  • 282 funds tracked by Wall St. Rank held DexCom as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.